MedPath
FDA Product

Pregabalin

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Pregabalin

62135-444

Regulatory Information

62135-444

ANDA212865

C73584

February 22, 2023

USA

Pregabalin Capsules These highlights do not include all the information needed to use PREGABALIN CAPSULES safely and effectively. See full prescribing information for PREGABALIN CAPSULES. Pregabalin Capsules, for oral use, CV Initial U.S. Approval: 2004

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

Chartwell RX, LLC

079394054

Active Ingredients

STARCH, CORN

Code: O8232NY3SJ

Class Code: IACT

SHELLAC

Code: 46N107B71O

Class Code: IACT

TALC

Code: 7SEV7J4R1U

Class Code: IACT

GELATIN, UNSPECIFIED

Code: 2G86QN327L

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

PROPYLENE GLYCOL

Code: 6DC9Q167V3

Class Code: IACT

ALCOHOL

Code: 3K9958V90M

Class Code: IACT

POTASSIUM HYDROXIDE

Code: WZH3C48M4T

Class Code: IACT

FERROSOFERRIC OXIDE

Code: XM0M87F357

Class Code: IACT

AMMONIA

Code: 5138Q19F1X

Class Code: IACT

PREGABALIN

Quantity: 50 mg in 1 1

Code: 55JG375S6M

Class Code: ACTIB

Active Moieties

PREGABALIN

Code: 55JG375S6M

© Copyright 2025. All Rights Reserved by MedPath